A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Clinical trial NCT05975073 · COMPLETED

Trial details

NCT number: NCT05975073
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

MTAP-null Non-Small-Cell Lung Cancer MTAP-null Solid Tumors

Start date: 2023-08-01
Primary completion: 2026-02-25
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.